Interestingly, we found that pOASL expression was activated in vitro at an earlier phase after viral infection and then declined (Fig. 3) and that the anti-CSFV effects of pOASL depend on enhancement of the type I IFN response, but not on the canonical RNase L pathway (Fig. 4 and 5). Here, RNASEL is linked to viral infectious disease.